Parkinson's Disease Clinical Trial
Official title:
The Study of Rest Tremor Suppression by Using Electrical Muscle Stimulation
This study is aimed to study the safety and feasibility of electrical muscle stimulation (EMS) in suppression of tremor from various causes especially for rest tremor in Parkinson's disease.
Study method as follows:
- All subjects will be provided the information on this research study and informed
consent will be sought for every subjects.
- All subjects (30 PD patients and 30 others tremor patients) will be interviewed by a
movement disorders specialist or a trained interviewer for their demographic and
clinical data.
- All PD patients will be examined for the severity of Parkinson's disease by a movement
disorders specialist according the Unified Parkinson's disease Rating Scale (UPDRS),
Hoehn and Yahr score, and tremor rating scale, during the 'on period' in order to
determine the additional effect of EMS for suppression of tremor. Physical examinations
of each patient will be recorded by the video recording for later reviewed.
- All essential tremor and dystonic tremor patients will be examined by a movement
disorders specialist for the tremor severity according to the Fahn, Tolosa, Marin
Tremor Rating Scale. Physical examinations of each patient will be recorded by the
video recording for later reviewed.
All patient will be determined for feasibility to use EMS and safety of EMS. Pain will
determined by visual analog scale.
- All patients will be monitored their hand tremor at resting position and postural
position. The tremor analysis with accelerometer and gyroscope system (Parkinson
Monitor V0.006 Beta) and the surface EMG (Nicolet EDX Viking) will be conducted. The
surface EMG electrode will place over thenar muscle of the hand, which is the most
predominant sided of tremor, for quantitative measurement and determination of tremor
physiology.
- All participants data from surface EMG will be applied to The Matlab™ program
(MathWorks Inc.) in order to modify the qualitative signals into quantitative
parameters and performing the high-dimensional feature vectors, and later to determine
the different efficacy in pulse amplitude of electrical muscle stimulation on feature
vectors.
- The electrical muscle stimulation (Intensity™ Twin Stim® III) will be conducted by
placement the 2 self-adhesive electrode (size 1.5 inches * 1.5 inches) over thenar
muscle and 1st&2nd interrosseous muscle of the hand, which is the most predominant
sided of tremor. The EMS will be stimulated PD patients on the rest position, whereas
the other tremors patients in both rest position and postural position. The pulse
amplitude will be slowly titration until provided the tetanic muscle contraction (motor
threshold) without pain (all applied frequency is 50 Hz).
- All of examination will be taken for 30 minutes for each one subject.
Data Collection
- Demographic and clinical data: age, gender, clinical diagnosis, disease's duration and
severity score for each subject according to establishing standard rating scale.
- Tremor parameters form Parkinson Monitor V0.006 Beta will be collected in both before
and during EMS as 5 parameters: Peak magnitude, RMS, Angle, Frequency, Q
- The pulse amplitude from EMS will be recorded in every titration in order to determine
the efficacy of EMS in difference pulse amplitude.
- The surface EMG and acceleration signal in difference pulse amplitude will be extracted
and clustered data in order to analyze by using Matlab™, and performed the
high-dimensional feature vectors for quantitative interpretation.
Data Analysis The statistical analysis in this study is based from SPSS program version 17.
Categorical data will be analyzed for frequency and percentage. Continuous data will be
analyzed by mean and standard deviation (SD). Non-parametric study would be preferred if the
small sample size or in case of distribution of data do not present as normal distribution
(determined by Kolmogorov-Smirnov test). The repeated ANOVA will be used for determined the
efficacy of difference pulse amplitude on tremor suppression and the efficacy of EMS in the
difference times in follow up periods.
;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02915848 -
Long-term Stability of LFP Recorded From the STN and the Effects of DBS
|
||
Recruiting |
NCT03648905 -
Clinical Laboratory Evaluation of Chronic Autonomic Failure
|
||
Terminated |
NCT02688465 -
Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).
|
Phase 4 | |
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Active, not recruiting |
NCT04006210 -
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
|
Phase 3 | |
Completed |
NCT02562768 -
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
|
Phase 1 | |
Completed |
NCT00105521 -
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
|
Phase 3 | |
Completed |
NCT00105508 -
Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia
|
Phase 3 | |
Recruiting |
NCT06002581 -
Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease
|
N/A | |
Completed |
NCT02236260 -
Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
|
N/A | |
Completed |
NCT00529724 -
Body Weight Gain, Parkinson, Subthalamic Stimulation
|
Phase 2 | |
Active, not recruiting |
NCT05699460 -
Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
|
||
Completed |
NCT03703570 -
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
|
Phase 2 | |
Completed |
NCT03462680 -
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
|
N/A | |
Completed |
NCT02837172 -
Diagnosis of PD and PD Progression Using DWI
|
||
Not yet recruiting |
NCT04046276 -
Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease
|
N/A | |
Recruiting |
NCT02952391 -
Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol
|
N/A | |
Active, not recruiting |
NCT02937324 -
The CloudUPDRS Smartphone Software in Parkinson's Study.
|
N/A | |
Completed |
NCT02927691 -
Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial
|
Phase 2 | |
Completed |
NCT02939391 -
A Study of KW-6356 in Subjects With Early Parkinson's Disease
|
Phase 2 |